Mutations and dysregulation of MAPK pathways, particularly ERK1/2, p38 MAPK and c‐Jun N‐terminal kinase (JNK) are observed in different subtypes of GBM, and correlated with cell differentiation, invasiveness, and metastatic behavior [20]. This evidence concerns the gene MAPK3 and glioblastoma.